Evolution Infographics
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam’s Thirty Year Journey to First Approval
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam’s Thirty Year Journey to First Approval
More
Share
Evolution Infographics
Global Drug Development IPOs: 26 Companies Raise Over $3.18B in Q3 as First Pre-Revenue Biotechs List in Hong Kong
Global Drug Development IPOs: 26 Companies Raise Over $3.18B in Q3 as First Pre-Revenue Biotechs List in Hong Kong
More
Share
News & Analysis
Democratising DNA: 23andMe & GSK Collaboration Highlights Data Quality & Privacy Concerns; Can Blockchain Offer a Disruptive Solution?
Democratising DNA: 23andMe & GSK Collaboration Highlights Data Quality & Privacy Concerns; Can Blockchain Offer a Disruptive Solution?
More
Share
Evolution Infographics
Global Drug Development IPOs: Over $2.5B Raised in Q2 with Market on Track for Best Year Since 2015
Global Drug Development IPOs: Over $2.5B Raised in Q2 with Market on Track for Best Year Since 2015
More
Share
Evolution Infographics
Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
More
Share
Evolution Infographics
All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
More
Share
Evolution Infographics
Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
More
Share
News & Analysis
More Efficient and Affordable Large-Scale Biomanufacturing: Have Novo Nordisk Foundation Made a Major Breakthrough?
More Efficient and Affordable Large-Scale Biomanufacturing: Have Novo Nordisk Foundation Made a Major Breakthrough?
More
Share
Evolution Infographics
Global Drug Development IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017
Global Drug Development IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017
More
Share
Evolution Infographics
Manufacturing Gene Therapies: An Impending Crisis or Temporary Growing Pains?
Manufacturing Gene Therapies: An Impending Crisis or Temporary Growing Pains?
More
Share
Evolution Infographics
Evaluating the Monogenic Gene Therapy Pipeline: Will Spark Therapeutics’ Luxturna Avoid the Fate of Glybera & Strimvelis?
Evaluating the Monogenic Gene Therapy Pipeline: Will Spark Therapeutics’ Luxturna Avoid the Fate of Glybera & Strimvelis?
More
Share
Evolution Infographics
Evotec Invests €15m in Exscientia in Latest Partnership between Big Pharma & Artificial Intelligence-Driven Drug Discovery
Evotec Invests €15m in Exscientia in Latest Partnership between Big Pharma & Artificial Intelligence-Driven Drug Discovery
More
Share